Lactose Intolerance Treatment Market Size at 9.4 Billion Revenue at 7.2% CAGR by 2023 | Market Research Future

Lactose Intolerance Treatment Market Highlights

The Global Lactose Intolerance Treatment Market is expected to reach $ 9.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 7.2 % during 2017-2023. Lactose intolerance cause symptoms such as abdominal pain, bloating, diarrhea, gas, nausea etc. due to the decreased ability to digest the sugar lactose in milk products. Lactose intolerance is caused due to the lack of enzyme lactase which breaks lactose into glucose and galactose. Primary lactose intolerance is due to fall in the amount of lactase due to age while secondary lactose intolerance is due to injury to the small intestine such as infections, celiac disease, inflammatory bowel disease etc. Congenital lactose intolerance is caused by genetic factors. The falling prices of lactose free foods due to rising scalability and larger sales will also stimulate the market. The non-serious nature of the symptoms of lactose intolerance is a major constraint on the market.

The global lactose intolerance treatment market is growing at a rate of 7.2 % and is expected show a similar trend during the forecast period. The falling prices of lactose free foods due to rising scalability and larger sales will also stimulate the market. The non-serious nature of the symptoms of lactose intolerance is a major constraint on the market. According to a recent study report published by the Market Research Future, the global lactose intolerance treatment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017 – 2023).

Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/3868

Segments

The global lactose intolerance treatment market is segmented on the basis of type, treatment and end users. Based on type, the market has been segmented as primary, secondary, developmental and congenital. Based on the treatment, the market has been segmented as food supplements (dairy, milk substitutes (soy, rice, coconut, almond, others), cereals and breads, fats, others), enzymatic lactase supplements, and others. Based on the end users, the market has been segmented as hospitals and clinics, home use, and others.

Key players of Global Lactose intolerance treatment Market:

Key players profiled in the report are Johnson & Johnson Inc., National Enzyme Company, Vetbiochem India Private Limited, Scimera Partners, Ganeden Biotech, Daiya Foods Inc., Arla Foods, McNeil Nutritionals, Oberland-Milchverwertung (OMIRA), Parmalat, Valio and others.

Intended Audience

Global Lactose intolerance treatment, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities
Global Lactose Intolerance Treatment Market – Regional Analysis

The lactose intolerance treatment market is chiefly driven by rise in awareness and greater screening rates in the world and especially in the developed regions of North America and Europe. The exact number of people with lactose intolerance is unknown but it is estimated that about 65% of the global population suffers from lactate intolerance. It is also estimated that lactate intolerance rates vary from less than 10% in Northern Europe to as high as 95% in parts of Asia and Africa. Moreover, In the UK, lactose intolerance is more common in people of Asian or African-Caribbean descent.

Lactose intolerance treatment market is estimated to be led by the developing regions of Asia Pacific which is further estimated to be dominated by China and India. Countries of the developing world such as Indonesia, Cambodia, China, and India is expected to be fastest growing segment for the market for lactose intolerance treatment in the Asia Pacific. The presence of large populations with unmet needs and the growing screening rates is the strongest driver of growth in these markets. Thus, there is larger potential to grow in the developing regions due to less competition. The growing number of lactose screening is the strongest factor responsible for the growth of the Asia Pacific market.

The Asia Pacific regions also have higher rates of lactose intolerance as compared to the western regions. It is estimated that at least 50-70% of non-white adults and up to 20% of Caucasians suffer from lactose intolerance and experience symptoms such as flatulence, cramp abdominal pain, diarrhoea, bloating, vomiting etc. the onset of Lactose intolerance is after 5 years of age. Lactose free milk substitutes become a necessity in infants because approximately 50% of their daily calories are derived from milk.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/lactose-intolerance-treatment-market-3868

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.